Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Banu Arun

Showing results (71-80 of 179) with videos related to

Pageof 18
Sort By:
The Oncologist|July 30, 2021
Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast CancerHumaid O Al-Shamsi, Ibrahim Abu-Gheida, Ahmed S Abdulsamad, et al.
Breast Cancer Research and Treatment|November 21, 2007
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal womenWei-Tse Yang, Mark Dryden, Kristine Broglio, et al.
Molecular Immunology|July 18, 2009
Anti-carbohydrate antibodies of normal sera: findings, surprises and challengesMargaret E Huflejt, Marko Vuskovic, Daniela Vasiliu, et al.
American Journal of Cancer Research|June 14, 2016
Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinibSunil Acharya, Jia Xu, Xiao Wang, et al.
Integrative Cancer Therapies|November 26, 2010
External qigong therapy for women with breast cancer prior to surgeryLorenzo Cohen, Zhen Chen, Banu Arun, et al.
Breast Cancer Research and Treatment|September 26, 2023
Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancersJing Wang, Hui Chen, Jenna Koenig, et al.
Cancer|July 29, 2006
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approachMassimo Cristofanilli, Savitri Krishnamurthy, Laura Guerra, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
Cancer|November 17, 2006
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution studyAnne Uyei, Susan K Peterson, Julie Erlichman, et al.
Cancer|August 18, 2015
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumorsRachel A Sanford, Juhee Song, Angelica M Gutierrez-Barrera, et al.
Pageof 18

Showing results (71-80 of 179) with videos related to

Sort By:
Pageof 18
The Oncologist|July 30, 2021
Molecular Spectra and Frequency Patterns of Somatic Mutations in Arab Women with Breast CancerHumaid O Al-Shamsi, Ibrahim Abu-Gheida, Ahmed S Abdulsamad, et al.
Breast Cancer Research and Treatment|November 21, 2007
Mammographic features of triple receptor-negative primary breast cancers in young premenopausal womenWei-Tse Yang, Mark Dryden, Kristine Broglio, et al.
Molecular Immunology|July 18, 2009
Anti-carbohydrate antibodies of normal sera: findings, surprises and challengesMargaret E Huflejt, Marko Vuskovic, Daniela Vasiliu, et al.
American Journal of Cancer Research|June 14, 2016
Downregulation of GLUT4 contributes to effective intervention of estrogen receptor-negative/HER2-overexpressing early stage breast disease progression by lapatinibSunil Acharya, Jia Xu, Xiao Wang, et al.
Integrative Cancer Therapies|November 26, 2010
External qigong therapy for women with breast cancer prior to surgeryLorenzo Cohen, Zhen Chen, Banu Arun, et al.
Breast Cancer Research and Treatment|September 26, 2023
Discordance of Oncotype DX scores in synchronous bilateral and unilateral multifocal breast cancersJing Wang, Hui Chen, Jenna Koenig, et al.
Cancer|July 29, 2006
A nonreplicating adenoviral vector that contains the wild-type p53 transgene combined with chemotherapy for primary breast cancer: safety, efficacy, and biologic activity of a novel gene-therapy approachMassimo Cristofanilli, Savitri Krishnamurthy, Laura Guerra, et al.
AMIA ... Annual Symposium Proceedings. AMIA Symposium|August 13, 2008
Building a predictive breast cancer risk modelConstance M Johnson, Joe Ensor, Kristine Broglio, et al.
Cancer|November 17, 2006
Association between clinical characteristics and risk-reduction interventions in women who underwent BRCA1 and BRCA2 testing: a single-institution studyAnne Uyei, Susan K Peterson, Julie Erlichman, et al.
Cancer|August 18, 2015
High incidence of germline BRCA mutation in patients with ER low-positive/PR low-positive/HER-2 neu negative tumorsRachel A Sanford, Juhee Song, Angelica M Gutierrez-Barrera, et al.
Pageof 18